Physician’s Grant Application
Physicians in the Jeffrey Modell Canadian Immunodeficiency Network are eligible to receive a grant of up to $5,000 Canadian. These funds are specifically restricted to the diagnosis and testing of patients with a suspected Primary Immunodeficiency and/or for physician education and public awareness. Physician symposia expenses such as conference facilities, audio-visual, printed material, coffee breaks, etc. can be funded under this program. Expenses for travel, hotel accommodations, honoraria, and personnel are discouraged.
Applicants will be advised of approval within 60 days from the date of submission through a letter outlining conditions for the grant and requirements of a short final report. Subsequent grants will only be considered after the final report has been received.
Examples of Previous Grants
Drs Ellie Haddad, Aubert Lavoie and Reza Alizadehfar for the Physician’s formation of Primary Immunodeficiency. This symposium intended to build awareness and education on the identification and diagnosis of PI among Quebec physicians. This event was open to every Quebec physician with an interest in treating PI.
The CI Society’s quarterly PID Video Conference series held at hospitals across Canada. It is a highly valuable medium to discuss difficult cases.
Dr. Christine McCusker of Montreal’s Children Hospital for Immunology rounds. This seminar series aided in the education of staff and trainees by discussing specific primarily immunodeficiencies and the genetic basis and management of immune disorders.
Dr. Amin Kanani held Immunodeficiency Rounds to promote new developments in understanding and treating Primary Immunodeficiency. Rounds were targeted to clinical immunologists, allergist and other sub-specialists from across Vancouver lower mainland.
Drs. Adelle Atkinson and Reza Alizadehfar for a 2nd Conference on Host Defense held during the Canadian Society of Allergy and Clinical Immunology Annual Scientific Meeting in Edmonton, Alberta. Hosted by the CI Society, opening comments, Dr. Chaim Roifman, Plenary lecture: Dr. Richard Stiehm, Moderators Drs. Adelle Atkinson & Reza Alizadehfar. Presentations: Dr. F. Le Deist – CD3 zeta deficiency, Dr. E. Grunebaum – Purine Immunodeficiency- novel treatments, Dr. S. Turvey – the emerging role of innate immunity. Followed by six short case presentations by fellows/network members, Moderators Drs. S Carr and A. Kanani.
Dr. Adelle Atkinson, Hospital for Sick Children, Toronto, Canada, to provide a series of lectures on primary immunodeficiencies, their diagnosis, work-up and management. These lectures would take place in the community as well as other healthcare institutions both community and university based.
Dr. Amin Kanani, University of British Columbia/St. Paul’s Hospital, Canada to provide two events for Primary Care Practitioners and three events for specialists. Topics included new developments in our understanding, recognizing, investigating and managing primary immune deficiencies. Discussion were also be held on challenging immunodeficiency cases.
Dr. Bruce Mazer, Montreal Children’s Hospital to host a symposium as part of the Annual Scientific Meeting of the Canadian Society of Allergy and Clinical Immunology in Montreal, October 2006.
The CI Society’s production and distribution of What is PI booklet aided patients and physicians in understanding how the immune system works, what PI is, and how it is diagnosed and treated in Canada. Distributed to hospitals across Canada.
Drs. Amin Kanani and Stuart Carr for a joint project, Do Bugs Need Drugs, which raised awareness of the 10 warning signs of Primary Immunodeficiency (25,000 copies of pamphlet distributed across British Columbia and Alberta).
Drs. Adelle Atkinson and Reza Alizadehfar, for a national physician awareness project aimed at educating physicians on the 10 warning signs of PI and raising awareness of the Network among physicians for support and consultations. Approximately 10, 500 physicians across Canada, within paediatrics and family practice, were provided resource and referral materials.